hypertensive patients.' In this study nifedipine plus diuretic lowered blood pressure more effectively than propranolol plus diuretic, which has previously been shown to be effective in black hypertensive patients.2 Although comparisons of fixed doses of drugs have limitations, the doses of propranolol and nifedipine used were in the middle of their therapeutic ranges. Experience in Kenyan hypertension clinics confirms reports that black hypertensive patients have lower plasma renin activities than white patients. Perhaps because of this, we found nifedipine plus diuretic to be an excellent combination for treating hypertension among black Kenyan patients.
In the Medical Research Council's randomised trial of elderly hypertensive patients, men receiving atenolol had a higher death rate from cancer than those receiving diuretic or placebo.' This was not observed in women receiving atenolol, whose mortality was similar to those receiving diuretic and lower than those receiving placebo. The extra cancer deaths were apparently from lung cancer. A randomised trial of elderly hypertensive patients in primary care reported a non-significant excess of fatal cancers of the bronchus in the group given atenolol compared with the control group (an excess risk of 1 89, 95% confidence interval 0-88 to 4 08). 2 We therefore examined the relation between atenolol treatment and cancer in a large study of hypertensive patients.
Methods and results
The Department of Health hypertension care computing project is a longitudinal study of A conditional multiple logistic regression analysis of our case-control study gave a relative risk from smoking of 4-2 (95% confidence interval 1 9 to 9 0, p < 0 0004) and from atenolol treatment of 0 9 (0 4 to 2-1, p=0 7). The only excess standardised mortality ratio was for renal cancer (ICD codes 1890-9) with a value of 196 (107 to 328, p=0 03) for men and women combined.
Comment
We found no evidence to support previous suggestions of an excess of cancer in men treated with (10 to 2-2) (0-9 to 2-2) (0-7 to 4-0) (0-6 to 3-9) atenolol
The strength of experimental studies is that randomisation removes selection bias. In the Medical Research Council's trial the relative risk of dying from cancer for men receiving atenolol was 1 9 compared with placebo (1-2 to 2 8) and 1-4 (0 9 to 2 2) compared with diuretic. In our study the 95% confidence intervals of the relative risks for all cancers and for lung cancer excluded a twofold excess risk from atenolol. We cannot exclude risks lower than this.
The following also participated in the DHCCP: L J Beilin, A Cohen, T A Jeffers, A D Munro-Faure, B E Rajagopolan, 0 J Robb, C Rossiter, and P B Rylance from hospitals and J B Davies, A P Douglas Jones, D Grant, E Horder, and J M Kenworthy Browne from general practice. We thank A Butler, D Hunt, G Massey and P W O'Riordan for programming and advice on computing. The study is principally funded by the Department of Health. We are also grateful for support provided by Schering Plough Ltd. The views in this paper reflect those of the authors and are independent of sponsorship. The variance of the distribution of the intervention rates did not change significantly during the study: the ratio of the largest variance to the smallest one (Fmax) was 1-7 for caesarean sections, 2-6 for epidural analgesia, and 3-3 for forceps and vacuum extractions. The figure shows that the rates of caesarean sections, epidural anaesthesia, and forceps and vacuum extractions went down in some matemity units but increased in most of them.
Department

Comment
We found no change of practice in our study, but this does not seem to be due to a lack of use of management awareness profiles by the matemity units. In 1990 we sent a questionnaire to the heads of the 49 matemity units that participated in the voluntary registration system in 1989. This showed that management awareness profiles were circulated to the staff in 30 of the 34 units that answered the relevant question. The increasing number of units participating in the system also indicates an interest in the management awareness profiles.
Feedback of information has been shown to change operative procedures in some non-randomised studies but not all. 3 The results of randomised controlled trials are less encouraging.45 Our results also suggest that awareness is not enough to change behaviour. Management awareness profiles are potentially useful, but mechanisms to make them effective in changing behaviour are still to be developed. Their long term effects will have to be evaluated.
